Cargando…
Drug and Disease Model Resources: A Consortium to Create Standards and Tools to Enhance Model-Based Drug Development
Model-based drug development (MBDD) is accepted as a vital approach in understanding patients' drug-related benefit and risk by integrating quantitative information integration from diverse sources collected throughout drug development.(1) This perspective introduces the activities of the Drug...
Autores principales: | Harnisch, L, Matthews, I, Chard, J, Karlsson, M O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615532/ https://www.ncbi.nlm.nih.gov/pubmed/23887647 http://dx.doi.org/10.1038/psp.2013.10 |
Ejemplares similares
-
Thoughtflow: Standards and Tools for Provenance Capture and Workflow Definition to Support Model‐Informed Drug Discovery and Development
por: Wilkins, JJ, et al.
Publicado: (2017) -
Modeling and Simulation as a Tool to Bridge Efficacy and Safety Data in Special Populations
por: Harnisch, L, et al.
Publicado: (2013) -
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
por: Swat, MJ, et al.
Publicado: (2015) -
Making Every Subject Count: A Case Study of Drug Development Path for Medication in a Pediatric Rare Disease
por: Bhattacharya, I, et al.
Publicado: (2016) -
Perspective on model‐informed drug development
por: Lesko, Lawrence J.
Publicado: (2021)